Virax Biolabs UK Operating Limited
Registered name: VIRAX BIOLABS UK OPERATING LIMITED
Part of Virax Biolabs Group Holdings Ltd groupVirax Biolabs UK Operating Limited made £932 revenue and a £242k loss in the year to 31 Mar 2025. read from filing text
Virax Biolabs UK Operating Limited’s revenue was £932 in the year to 31 Mar 2025, with a loss of £242k and 2 employees. The company is classified under “activities of other holding companies” and is based in Newhouse.
- Status
- Active
- Location
- Newhouse, Scotland
- Age
- 2 yrs · since 2023
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company is controlled on a day to day basis by the directors but the main controlling party is by Virax Biolabs Group Limited which is a company registered in”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2025 |
|---|---|
| Disclosure | Full P&Lread from filing text |
| Profit & loss | |
| Revenue (turnover) | £932 |
| Cost of sales | £757 |
| Gross profit | £175 |
| Profit before tax | −£242k |
| Profit after tax | −£242k |
| Profit (best available) | −£242k |
| Staff costs | £107k |
| Employees (average) | 2 |
| Ratios | |
| Profit margin | −25926% |
| Gross margin | 18.8% |
| Revenue per employee | £466 |
| Profit per employee | −£121k |
| Balance sheet — indirect signals, not revenue | |
| Cash at bank | £149k |
| Net assets | −£242k |
| Current assets | £164k |
| Debtors | £14.5k |
| Deferred income | £19.6k |
| Source | FullAccounts · bulk data Jul 2025 |
How the business works
- Profit margin
- −25926%
- Profit ÷ revenue.
- Gross margin
- 18.8%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £466
- Revenue ÷ average employees.
- Profit per employee
- −£121k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 2108%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 1555%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£242k
- Cash at bank
- —
- Now £149k
- Headcount
- —
- Now 2
- Deferred income
- —
- Now £19.6k
- Fixed assets
- —
- Now —
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Virax Biolabs Group Holdings Ltdultimate parent75–100%
- Virax Biolabs UK Operating Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£242k), from the Companies House accounts bulk data published Jul 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.